HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.

CME information and select publications here.

Community discussion

Join the conversation

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

You May Also Like

Vedanta Cast

Mundo Insólito Radio

This Week in Microbiology

Real Ghost Stories Online

The Grave Talks | Haunted, Paranormal & Supernatural

Head Shepherd

Accès au Marché Mondial des Dispositifs Médicaux

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra

John Michael Godier's Event Horizon

The Climate Question